Direkt zum Inhalt
Merck
  • Biphenyl hydroxylation enhanced by an engineered o-xylene dioxygenase from Rhodococcus sp. strain DK17.

Biphenyl hydroxylation enhanced by an engineered o-xylene dioxygenase from Rhodococcus sp. strain DK17.

Research in microbiology (2011-05-18)
Miyoun Yoo, Dockyu Kim, Gerben J Zylstra, Beom Sik Kang, Eungbin Kim
ZUSAMMENFASSUNG

Hydroxylation of the non-growth substrate biphenyl by recombinant o-xylene dioxygenases from Rhodococcus sp. strain DK17 was studied through bioconversion experiments. The metabolites from the biphenyl hydroxylation by each enzyme were identified and quantified by gas chromatography-mass spectrometry. The L266F mutant enzyme produced much more 2-hydroxybiphenyl (2.43 vs. 0.1 μg/L) and 3-hydroxybiphenyl (1.97 vs. 0.03 μg/L) than the wild-type. Site-directed mutagenesis combined with structural and functional analyses indicated that hydrophobic interactions and shielding effects against water are important factors in the hydroxylation of biphenyl by the o-xylene dioxygenase. The residue at position 266 plays a key role in coordinating the reaction.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Xylole, histological grade
Sigma-Aldrich
Xylole, ACS reagent, ≥98.5% xylenes + ethylbenzene basis
Sigma-Aldrich
Xylole, reagent grade
Sigma-Aldrich
o-Xylen, reagent grade, ≥98.0%
Sigma-Aldrich
o-Xylen, anhydrous, 97%
Supelco
o-Xylen, analytical standard
Supelco
o-Xylen, Pharmaceutical Secondary Standard; Certified Reference Material